Merrimack Pharmaceuticals (ONIVYDE)

Business Data, Corporate Office and Headquarter Address

About

Merrimack Pharmaceuticals (ONIVYDE) is Buildings and Property in United States that focus on Cancer pharmaceutical asset business. They cover business area such as cancer pharmaceutical asset, onivyde (irinotecan liposome injection, patient, metastatic adenocarcinoma, disease progression, gemcitabine?based therapy.

Business Type

Buildings and Property

Country

United States

Founded

-

Company Focus

Cancer Pharmaceutical Asset

Website

-

Corporate Office and Headquarter Office address:

One Kendall Square, Building 700
Suite B7201
Cambridge, MA 02139
United States

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

cancer pharmaceutical assetonivyde (irinotecan liposome injectionpatientmetastatic adenocarcinomadisease progressiongemcitabine?based therapy

* We use standard office opening hours in near Merrimack Pharmaceuticals (ONIVYDE)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Merrimack Pharmaceuticals (ONIVYDE) Frequently Asked Questions

What or who is Merrimack Pharmaceuticals (ONIVYDE)?

Merrimack Pharmaceuticals (ONIVYDE) is Buildings and Property business from United States that founded in - ( years old in ), Merrimack Pharmaceuticals (ONIVYDE) business is focusing on Cancer Pharmaceutical Asset.

Where is Merrimack Pharmaceuticals (ONIVYDE) headquarter and corporate office address?

Merrimack Pharmaceuticals (ONIVYDE) headquarter office and corporate office address is located in One Kendall Square, Building 700 Suite B7201 Cambridge, MA 02139 United States.

Where is Merrimack Pharmaceuticals (ONIVYDE) country origins?

Merrimack Pharmaceuticals (ONIVYDE) was founded in United States.

What is Cancer Pharmaceutical Asset business focus on?

In , Merrimack Pharmaceuticals (ONIVYDE) is currently focus on Cancer pharmaceutical asset sector.

Cancer Pharmaceutical Asset Business Interest from Google Trend

Above is snippet of Google Trends for "Cancer pharmaceutical asset" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with Merrimack Pharmaceuticals (ONIVYDE), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.